Awards Nomination 20+ Million Readerbase
Indexed In
  • Academic Journals Database
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • Scimago
  • Ulrich's Periodicals Directory
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
Share This Page

Daniel A. Pollyea

Daniel A. Pollyea

Daniel A. Pollyea
Stanford University Cancer Center, USA

Research Interest

Investigator initiated Phase I/II clinical trial of azacitidine in combination with lenalidomide for elderly, previously untreated AML patients (PI), Characterization of the structure, function and prognostic value of the TET2 gene in myeloid malignancies.